Puisieux A - Search Results

1

[Immunotherapy of poor-prognosis neuroblastoma in children: from bench to bedside].

Rousseau R, Combaret V, Yvon E, Schell M, Philip I, Puisieux A, Frappaz D, Philip T, Bergeron C. Rousseau R, et al. Among authors: puisieux a. Bull Cancer. 2006 Feb;93(2):153-61. Bull Cancer. 2006. PMID: 16517413 Free article. Review. French.

2

Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E, Puisieux A. Wang Q, et al. Among authors: puisieux a. Cancer Res. 1999 Jan 15;59(2):294-7. Cancer Res. 1999. PMID: 9927034

3

Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients.

Combaret V, Audoynaud C, Iacono I, Favrot MC, Schell M, Bergeron C, Puisieux A. Combaret V, et al. Among authors: puisieux a. Cancer Res. 2002 Jul 1;62(13):3646-8. Cancer Res. 2002. PMID: 12097268

4

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A. Valsesia-Wittmann S, et al. Among authors: puisieux a. Cancer Cell. 2004 Dec;6(6):625-30. doi: 10.1016/j.ccr.2004.09.033. Cancer Cell. 2004. PMID: 15607966 Free article.

5

Protein chip array profiling analysis of sera from neuroblastoma patients.

Combaret V, Bergeron C, Bréjon S, Iacono I, Perol D, Négrier S, Puisieux A. Combaret V, et al. Among authors: puisieux a. Cancer Lett. 2005 Oct 18;228(1-2):91-6. doi: 10.1016/j.canlet.2004.12.053. Cancer Lett. 2005. PMID: 15922509 Review.

6

Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.

Krause A, Combaret V, Iacono I, Lacroix B, Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B, Puisieux A. Krause A, et al. Among authors: puisieux a. Cancer Lett. 2005 Jul 8;225(1):111-20. doi: 10.1016/j.canlet.2004.10.035. Epub 2004 Dec 8. Cancer Lett. 2005. PMID: 15922863 Free article.

7

Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma.

Combaret V, Bergeron C, Noguera R, Iacono I, Puisieux A. Combaret V, et al. Among authors: puisieux a. J Clin Oncol. 2005 Dec 1;23(34):8919-20; author reply 8920. doi: 10.1200/JCO.2005.04.0170. J Clin Oncol. 2005. PMID: 16314658 No abstract available.

8

[Cancer cells escape from failsafe programs in a simple Twist].

Puisieux A, Valsesia-Wittmann S. Puisieux A, et al. Bull Cancer. 2006 Mar 1;93(3):251-6. Bull Cancer. 2006. PMID: 16567311 Free article. Review. French.

9

Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity.

Combaret V, Boyault S, Iacono I, Brejon S, Rousseau R, Puisieux A. Combaret V, et al. Among authors: puisieux a. Mol Cancer. 2008 Jun 5;7:50. doi: 10.1186/1476-4598-7-50. Mol Cancer. 2008. PMID: 18534018 Free PMC article.

10

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.

Janoueix-Lerosey I, Lequin D, Brugières L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, Valteau-Couanet D, Frebourg T, Michon J, Lyonnet S, Amiel J, Delattre O. Janoueix-Lerosey I, et al. Among authors: puisieux a. Nature. 2008 Oct 16;455(7215):967-70. doi: 10.1038/nature07398. Nature. 2008. PMID: 18923523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page